{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "15835775",
      "primarysourcecountry": "GB",
      "occurcountry": "GB",
      "transmissiondateformat": "102",
      "transmissiondate": "20190417",
      "reporttype": "1",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20190117",
      "receiptdateformat": "102",
      "receiptdate": "20190117",
      "fulfillexpeditecriteria": "1",
      "authoritynumb": "GB-MHRA-EYC 00192252",
      "companynumb": "GB-TEVA-2019-GB-998977",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "TEVA",
        "duplicatenumb": "GB-TEVA-2019-GB-998977"
      },
      "primarysource": {
        "reportercountry": "GB",
        "qualification": "3"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "54",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Pharyngeal oedema",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Vertigo",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Anxiety",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Tremor",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Dysphagia",
            "reactionoutcome": "1"
          },
          {
            "reactionmeddraversionpt": "21.1",
            "reactionmeddrapt": "Chest discomfort",
            "reactionoutcome": "1"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "COPAXONE",
            "drugbatchnumb": "10720",
            "drugauthorizationnumb": "20622023",
            "drugstructuredosagenumb": "40",
            "drugstructuredosageunit": "003",
            "drugadministrationroute": "058",
            "drugindication": "MULTIPLE SCLEROSIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20181221",
            "drugenddateformat": "102",
            "drugenddate": "20181221",
            "actiondrug": "6",
            "activesubstance": {
              "activesubstancename": "GLATIRAMER ACETATE"
            },
            "openfda": {
              "application_number": [
                "NDA020622"
              ],
              "brand_name": [
                "COPAXONE"
              ],
              "generic_name": [
                "GLATIRAMER ACETATE"
              ],
              "manufacturer_name": [
                "Teva Neuroscience, Inc."
              ],
              "product_ndc": [
                "68546-317",
                "68546-325"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "GLATIRAMER ACETATE"
              ],
              "rxcui": [
                "1111641",
                "1111642",
                "1487361",
                "1487363"
              ],
              "spl_id": [
                "11a58ba0-b865-49e6-86e3-eb9bb58341e5"
              ],
              "spl_set_id": [
                "aa88f583-4f5f-433b-80b4-1f4c9fb28357"
              ],
              "package_ndc": [
                "68546-317-00",
                "68546-317-30",
                "68546-325-06",
                "68546-325-12"
              ],
              "unii": [
                "5M691HL4BO"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CANNABIDIOL",
            "activesubstance": {
              "activesubstancename": "CANNABIDIOL"
            },
            "openfda": {
              "application_number": [
                "NDA210365"
              ],
              "brand_name": [
                "EPIDIOLEX"
              ],
              "generic_name": [
                "CANNABIDIOL"
              ],
              "manufacturer_name": [
                "Jazz Pharmaceuticals, Inc."
              ],
              "product_ndc": [
                "70127-100"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "CANNABIDIOL"
              ],
              "rxcui": [
                "2058900",
                "2058906"
              ],
              "spl_id": [
                "1eb7ac65-8df5-4a4a-9156-802cfaa92b06"
              ],
              "spl_set_id": [
                "8bf27097-4870-43fb-94f0-f3d0871d1eec"
              ],
              "package_ndc": [
                "70127-100-01",
                "70127-100-10",
                "70127-100-06",
                "70127-100-60"
              ],
              "nui": [
                "M0003267",
                "N0000187062",
                "N0000185504",
                "N0000182140",
                "N0000191278",
                "N0000191273",
                "N0000182138",
                "N0000182139",
                "N0000187064"
              ],
              "pharm_class_cs": [
                "Cannabinoids [CS]"
              ],
              "pharm_class_moa": [
                "Cytochrome P450 2C8 Inhibitors [MoA]",
                "Cytochrome P450 2C9 Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]",
                "UGT1A9 Inhibitors [MoA]",
                "UGT2B7 Inhibitors [MoA]",
                "Cytochrome P450 1A2 Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inhibitors [MoA]",
                "Cytochrome P450 2B6 Inducers [MoA]"
              ],
              "unii": [
                "19GBJ60SN5"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VITAMIN D",
            "activesubstance": {
              "activesubstancename": "CHOLECALCIFEROL"
            },
            "openfda": {
              "application_number": [
                "ANDA090455"
              ],
              "brand_name": [
                "VITAMIN D"
              ],
              "generic_name": [
                "ERGOCALCIFEROL"
              ],
              "manufacturer_name": [
                "Strides Pharma Science Limited"
              ],
              "product_ndc": [
                "64380-737"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ERGOCALCIFEROL"
              ],
              "rxcui": [
                "1367410"
              ],
              "spl_id": [
                "1cc589f7-cd6d-40a6-8fce-c965e8945eae"
              ],
              "spl_set_id": [
                "2c4c0a36-12cf-444d-9d57-de983eef4d36"
              ],
              "package_ndc": [
                "64380-737-06",
                "64380-737-25"
              ],
              "nui": [
                "M0007651",
                "N0000175909"
              ],
              "pharm_class_cs": [
                "Ergocalciferols [CS]"
              ],
              "pharm_class_epc": [
                "Provitamin D2 Compound [EPC]"
              ],
              "unii": [
                "VS041H42XC"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "MAGNESIUM",
            "activesubstance": {
              "activesubstancename": "MAGNESIUM"
            },
            "openfda": {
              "brand_name": [
                "BYE ZERO",
                "DETOX TOC TOC"
              ],
              "generic_name": [
                "MAGNESIUM"
              ],
              "manufacturer_name": [
                "Korea Life Science"
              ],
              "product_ndc": [
                "87414-0002",
                "87414-0001"
              ],
              "product_type": [
                "HUMAN OTC DRUG"
              ],
              "route": [
                "TOPICAL"
              ],
              "substance_name": [
                "MAGNESIUM"
              ],
              "spl_id": [
                "4a0e3f61-9668-eb5f-e063-6294a90a9a71",
                "47ec6495-06c3-1f32-e063-6294a90a6b88"
              ],
              "spl_set_id": [
                "4a0e3f5d-f0cd-09ff-e063-6294a90ad282",
                "47ec6277-e411-af82-e063-6294a90ac8c1"
              ],
              "package_ndc": [
                "87414-0002-1",
                "87414-0001-1"
              ],
              "unii": [
                "I38ZP9992A"
              ]
            }
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 20181221"
        }
      }
    }
  ]
}